DGAP-Adhoc: SYGNIS AG announces subscription price for new shares in a capital increase to finance the acquisition of Expedeon Holdings Ltd.


SYGNIS AG  / Key word(s): Capital Increase

24.06.2016 21:30

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Ad hoc announcement according to § 15 WpHG

---------------------------------------------------------------------------
NOT FOR DISTRIBUTION, PUBLICATION, OR TRANSMISSION IN THE USA, CANADA,
JAPAN AND AUSTRALIA


SYGNIS AG announces subscription price for new shares in a capital increase
to finance the acquisition of Expedeon Holdings Ltd.


  - Subscription price set at EUR 1.10

  - Subscription period is expected to start on the 29th of June 2016,
    subject to approval of the prospectus


Madrid, Spain and Heidelberg, Germany, 24 June 2016 -  SYGNIS AG
(Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today set, with the
approval of the Supervisory Board, the subscription price for the announced
cash capital increase to finance the acquisition of Expedeon Holdings Ltd.
at EUR 1.10 per new share.

As announced in the Company's ad hoc announcement on 9 May 2016 and in
order to finance the acquisition of Expedeon Holdings Ltd., SYGNIS will
increase its share capital by up to EUR 20,538,089.00 from EUR
16,803,891.00 up to EUR 37,341,980.00 by issuing up to 20,538,089 new
shares by way of a rights offering. Any new shares not subscribed by SYGNIS
or Expedeon shareholders will be offered to qualified investors in a
private placement at EUR 1.10 per new share. Expected proceeds from the
capital increase will be used for transaction-related expenses, including
EUR 1.7 million cash payments to Expedeon shareholders, one-off integration
costs and financing of the working capital. The subscription period is
expected to start on the 29th of June 2016, subject to approval of the
prospectus.

The subscription offer as well as the prospectus once approved will be
published  on the website of SYGNIS AG www.sygnis.com/investors.


*** end of ad hoc announcement  ***


For further information please contact:


SYGNIS AG                         MC Services AG
Pilar de la Huerta                Raimund Gabriel
CEO/CFO                           Managing Partner
Phone: +34 91 192 36 50           Phone: +49 89 210228 30
Email: pdelahuerta@sygnis.com     Email: raimund.gabriel@mc-services.eu



About SYGNIS AG: www.sygnis.com
SYGNIS, headquartered in Germany and Spain, specializes in the development
and commercialization of innovative products for DNA amplification and
sequencing. Based on its proprietary technologies, SYGNIS has developed a
commercial product portfolio addressing key challenges in the fast-growing
fields of molecular biology and next-generation sequencing applications.
Key products include the TruePrime(TM) product line and SensiPhi(R),
licensed to a leading industry partner, for whole genome DNA amplification
and sequencing, as well as the SunScript(TM) Reverse Transcriptase product
family to convert genetic information from RNA molecules back to DNA.
SYGNIS AG is listed on the German Stock Exchange in the Prime Standard
segment (Ticker: LIO1; ISIN: DE000A1RFM03).

### This document is not a securities prospectus and the information
contained herein does not constitute an offer to sell or a solicitation of
an offer to purchase any securities of SYGNIS AG in the Federal Republic of
Germany nor under any other jurisdiction, in particular not where such kind
of offer or solicitation is prohibited or lacks the required permission.
Potential investors in securities of SYGNIS AG are asked to familiarize
themselves with and to observe the respective restrictions.

A decision to invest in the securities of SYGNIS AG should only be made on
the basis of the securities prospectus detailing the public offering of
securities of SYGNIS AG in the Federal Republic of Germany, which, subject
to the approval of the German Federal Financial Supervisory Authority
(BaFin) is anticipated to be published under www.sygnis.com/investors.

The information in this document may not be disseminated outside the
Federal Republic of Germany in particular not in the United States, to U.S.
Persons (as defined in Regulation S of the U.S. Securities Act of 1933) or
to publications with a general circulation in the United States with the
exception of such disclosures or announcements outside the Federal Republic
of Germany which have to be made under the respective mandatory law. Any
person who fails to comply with these restrictions may violate the
securities laws of certain jurisdictions, in particular of the United
States. Securities in SYGNIS AG are not publicly offered outside the
Federal Republic of Germany.

Some statements included in this ad hoc announcement, relating neither to
proven financial results nor other historical data, should be viewed as
forward-looking, i.e. not definite. Such statements are mainly predictions
of future results, trends, plans or goals. These statements should not be
considered to be total guarantees since, given their very nature, they are
subject to known and unknown risks and uncertainties and can be affected by
other factors as a consequence of which the actual results, plans and goals
of SYGNIS AG may deviate greatly from the established conclusions or
implied predictions contained in such statements. SYGNIS does not undertake
to publicly update or revise these statements in light of new information
or future results or for any other reason. ###


24.06.2016 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      SYGNIS AG
              Waldhofer Str. 104
              69123 Heidelberg
              Germany
Phone:        +49 (0) 6221 3540 125
Fax:          +49 (0) 6221 3540 127
E-mail:        investors@sygnis.com
Internet:     www.sygnis.com
ISIN:         DE000A1RFM03
WKN:          A1RFM0
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated
              Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich,
              Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------